Credit: Celltrion Avtozma, formerly known as CT-P47, is an interleukin-6 receptor antagonist. Findings showed tocilizumab-anoh had comparable efficacy, pharmacokinetics, safety, and immunogenicity ...
The US Food and Drug Administration (FDA) has approved the biosimilar tocilizumab-aazg (Tyenne), Fresenius Kabi, the drug's manufacturer, announced today. This is the second tocilizumab biosimilar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results